Mounjaro mounts to top spot in Indian drug market; Oct sales touch ₹100 cr, ETPharma
New Delhi: Maintaining its growth momentum for the seventh straight month, Eli Lilly’s type-2 diabetes and weight-loss drug…
GLP-1 goliath updates demand for top weight loss drug
Novo Nordisk reported Q3 2025 earnings on November 5, showing continued strong demand for its weight-loss drug Wegovy,…
Is Eli Lilly a Millionaire Maker?
Eli Lilly’s GLP-1 drug portfolio should power the business for at least the next decade. But the market…
Ozempic at Costco? Discount Giant Expands Into $100 Billion Weight-Loss Drug Market
Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. Costco…
Warning after ‘King Kong’ of weight-loss jabs found being sold illegally on social media
Fake versions of highly sought-after weight-loss jabs are being sold illegally on social media, an investigation has found.…
Ozempic coming soon to India: What is it? Benefits, side effects and controversies
India’s drug controller, the Central Drugs Standard Control Organisation (CDSCO), approved Ozempic (semaglutide) on 26 September for use…
1 Reason Novo Nordisk (NVO) Is 1 of the Best Healthcare Stocks You Can Buy Today
Novo Nordisk is leading the race to get an oral weight loss GLP-1 drug approved. It needs to…
How the ‘Ozempic effect’ is reshaping the global economy
Michael Siluk/Alamy The new wave of weight-loss drugs has taken the world by storm. From Novo Nordisk’s Ozempic…
Health Sector Sees Mixed Developments: Resolutions, Delays, and Innovations
The U.S. Food and Drug Administration announced a resolution to the nation’s saline shortage, a move easing…
Will you take Wegovy to lose weight?
Wegovy is now available in Singapore more than two years after it was approved by the Health Sciences…
As a reporter, I’ve covered all things GLP-1. Here’s what I’ve learned.
I have to admit: When I was assigned to write my first story about the blockbuster weight loss…